intracoronary stenting


Also found in: Dictionary.

intracoronary stenting

Coronary stenting Cardiology A treatment for vessel closure after percutaneous transluminal coronary angioplasty which ↓ the rate of restenosis, in which a cylindrical stent is placed within vessel(s) that are stenosed by atheroscerotic lesions Complications Thrombotic occlusion of stent, hemorrhage and peripheral vascular complications due to intensive anticoagulation

per·cu·ta·ne·ous co·ro·nar·y in·ter·ven·tion

(PCI) (pĕr'kyū-tā'nē-ŭs kōr'ŏ-nar'ē in'tĕr-ven'shŭn)
The treatment modality used during cardiac catheterization to reduce or remove occlusion within the coronary arteries and increase perfusion to the myocardium. PCIs include atherectomy, brachytherapy, stent implantation, angioplasty, and laser revascularization.
Synonym(s): intracoronary stenting.
References in periodicals archive ?
Supply intracoronary stenting and angioplasty balonoion
Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: Final results of the intracoronary stenting and angiographic restenosis--test equivalence between 2 drug-eluting stents (ISAR-TEST) trial.
director of Clinical Research and Data Coordinating, Intracoronary Stenting and Antithrombosis Research (ISAR) Center, German Heart Center in Munich.
A significant and independent prognostic role of CRP on both major adverse events and angiographic restenosis was later shown in 276 patients undergoing intracoronary stenting (P = 0.
As this field evolves, and as the price of stents decreases, it may be expected that the overall clinically favorable results seen with intracoronary stenting will be reflected in an overall shorter length of stay, and an overall lower cost.
The publication of these long-term outcomes has been much anticipated by interventional cardiologists who have already broadly adopted INTEGRILIN usage at time of intracoronary stenting.
The Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 3 (ISAR-REACT 3) study is being presented today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago.
Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.
Food and Drug Administration has approved revised prescribing information for INTEGRILIN(R) to include a new dosing regimen for patients undergoing percutaneous coronary intervention and specific reference within the product's indications for use in patients undergoing intracoronary stenting.
Treatment of spontaneous coronary artery dissection with intracoronary stenting.
amp;uot;The results of this study reinforce our conviction that GP IIb-IIIa inhibitors should be the standard of care for patients undergoing intracoronary stenting.